Lyra Therapeutics Stock Alpha and Beta Analysis
| LYRA Stock | USD 0.19 0.01 5.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Lyra Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Lyra Therapeutics over a specified time horizon. Remember, high Lyra Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Lyra Therapeutics' market risk premium analysis include:
Beta 1.31 | Alpha (0.78) | Risk 6.44 | Sharpe Ratio (0.09) | Expected Return (0.59) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Lyra |
Lyra Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Lyra Therapeutics market risk premium is the additional return an investor will receive from holding Lyra Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Lyra Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Lyra Therapeutics' performance over market.| α | -0.78 | β | 1.31 |
Lyra Therapeutics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Lyra Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how Lyra Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Lyra Therapeutics Market Price Analysis
Market price analysis indicators help investors to evaluate how Lyra Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lyra Therapeutics shares will generate the highest return on investment. By understating and applying Lyra Therapeutics stock market price indicators, traders can identify Lyra Therapeutics position entry and exit signals to maximize returns.
Lyra Therapeutics Return and Market Media
The median price of Lyra Therapeutics for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 is 0.26 with a coefficient of variation of 15.11. The daily time series for the period is distributed with a sample standard deviation of 0.04, arithmetic mean of 0.25, and mean deviation of 0.03. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Acquisition by Merrifield C Ann of 3500 shares of Lyra Therapeutics at 4.813 subject to Rule 16b-3 | 09/10/2024 |
2 | Lyra Therapeutics, Inc. Given Average Rating of Hold by Analysts | 09/16/2024 |
3 | Lyra Therapeutics stock plunges to 52-week low of 0.24 - Investing.com | 10/03/2024 |
4 | Acquisition by Jason Cavalier of 100000 shares of Lyra Therapeutics subject to Rule 16b-3 | 10/16/2024 |
5 | Lyra Therapeutics, Inc. Short Interest Down 24.9 percent in October | 10/30/2024 |
6 | Lyra Therapeutics Inc Q3 2024 Earnings Net Loss of 11.9M, Misses EPS and Revenue Estimates | 11/12/2024 |
About Lyra Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Lyra or other stocks. Alpha measures the amount that position in Lyra Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 (projected) | Graham Number | 7.13 | 14.15 | Receivables Turnover | 6.7 | 5.96 |
Lyra Therapeutics Upcoming Company Events
As portrayed in its financial statements, the presentation of Lyra Therapeutics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Lyra Therapeutics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Lyra Therapeutics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Lyra Therapeutics. Please utilize our Beneish M Score to check the likelihood of Lyra Therapeutics' management manipulating its earnings.
| 3rd of April 2024 Upcoming Quarterly Report | View | |
| 10th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 3rd of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Lyra Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Lyra Therapeutics Backtesting, Lyra Therapeutics Valuation, Lyra Therapeutics Correlation, Lyra Therapeutics Hype Analysis, Lyra Therapeutics Volatility, Lyra Therapeutics History and analyze Lyra Therapeutics Performance. For information on how to trade Lyra Stock refer to our How to Trade Lyra Stock guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Lyra Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.